| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Symes JF | |
| Isner JM | |||
| Losordo DW | |||
| Vale PR | |||
| P2860 | cites work | Regulation of endothelium-derived nitric oxide production by the protein kinase Akt | Q22010149 |
| P433 | issue | 5 | |
| P921 | main subject | gene therapy | Q213901 |
| human subject research project | Q1331083 | ||
| circulatory system | Q11068 | ||
| P304 | page(s) | 389-400 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | Circulation Research | Q2599020 |
| P1476 | title | Assessment of risks associated with cardiovascular gene therapy in human subjects | |
| P478 | volume | 89 |
| Q45871974 | 10-year safety follow-up in patients with local VEGF gene transfer to ischemic lower limb |
| Q35778966 | A problem-oriented approach to safety issues in drug development and beyond |
| Q34667599 | Active Rac1 improves pathologic VEGF neovessel architecture and reduces vascular leak: mechanistic similarities with angiopoietin-1 |
| Q43619839 | Adenoviral-mediated gene transfer of vascular endothelial growth factor in critical limb ischemia: safety results from a phase I trial |
| Q37636817 | Adenovirus-mediated transfer of VEGF into marrow stromal cells combined with PLGA/TCP scaffold increases vascularization and promotes bone repair in vivo |
| Q35093601 | Adult stem cell therapy for heart failure |
| Q37766138 | Advances in gene-based therapy for heart failure |
| Q31113638 | Angiogenesis by implantation of peripheral blood mononuclear cells and platelets into ischemic limbs |
| Q36288905 | Angiogenic and antiangiogenic gene therapy |
| Q34788546 | Arteriogenic therapy based on simultaneous delivery of VEGF-A and FGF4 genes improves the recovery from acute limb ischemia |
| Q45876829 | Autologous vascular smooth muscle cell-based myocardial gene therapy to induce coronary collateral growth |
| Q36812099 | Brain-derived neurotrophic factor: a newly described mediator of angiogenesis |
| Q35915765 | Cardiovascular gene delivery: The good road is awaiting |
| Q35995220 | Cardiovascular gene therapy: current status and therapeutic potential. |
| Q64099363 | Comparison of Mean VEGF-A Expression Between Acute Ischemic Stroke Patients and Non-Ischemic Stroke Subjects |
| Q36931967 | Current strategies for myocardial gene delivery |
| Q36909367 | Engineering blood vessels by gene and cell therapy |
| Q24791063 | Gene Therapy for Cardiovascular Disease |
| Q37204529 | Gene and stem cell therapy in peripheral arterial occlusive disease |
| Q37776515 | Gene therapy and angiogenesis in patients with coronary artery disease |
| Q35164797 | Gene therapy for cardiovascular angiogenesis |
| Q35045240 | Gene therapy for cerebral vascular disease: update 2003. |
| Q24187841 | Gene therapy for peripheral arterial disease |
| Q24246814 | Gene therapy for peripheral arterial disease |
| Q36786243 | Gene therapy in the treatment of heart failure |
| Q36477718 | Gene therapy of the ischemic lower limb--Therapeutic angiogenesis. |
| Q35141791 | Gene transfer as a tool to induce therapeutic vascular growth |
| Q36304278 | Gene transfer for ischemic cardiovascular disease: is this the end of the beginning or the beginning of the end? |
| Q35218706 | Gene-based therapeutic angiogenesis |
| Q40607304 | High glucose enhances interleukin-6-induced vascular endothelial growth factor 165 expression via activation of gp130-mediated p44/42 MAPK-CCAAT/enhancer binding protein signaling in gingival fibroblasts. |
| Q37406656 | Human studies of angiogenic gene therapy |
| Q37242381 | In vivo properties of the proangiogenic peptide QK |
| Q33977026 | Indirect imaging of cardiac-specific transgene expression using a bidirectional two-step transcriptional amplification strategy. |
| Q45858618 | Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia |
| Q40703867 | Left ventricular targeting of reporter gene expression in vivo by human BNP promoter in an adenoviral vector |
| Q45981429 | Localized arteriole formation directly adjacent to the site of VEGF-induced angiogenesis in muscle. |
| Q38081027 | Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors |
| Q40553670 | Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis |
| Q35020341 | Molecular approaches for the treatment of atherosclerosis |
| Q36174173 | New vectors and strategies for cardiovascular gene therapy |
| Q39602637 | Non-invasive bioluminescence imaging of myoblast-mediated hypoxia-inducible factor-1 alpha gene transfer |
| Q36226806 | Non-viral vectors for gene therapy: clinical trials in cardiovascular disease |
| Q44123397 | Phase I study of direct administration of a replication deficient adenovirus vector containing the vascular endothelial growth factor cDNA (CI-1023) to patients with claudication |
| Q31072359 | Regulation of angiogenesis by the aging suppressor gene klotho |
| Q51370544 | Serum hepatocyte growth factor levels predict long-term clinical outcome after percutaneous coronary revascularization. |
| Q37665063 | Stem cell-mediated neovascularization in heart repair |
| Q73443589 | Synergistic effect of angiopoietin-1 and vascular endothelial growth factor on neoangiogenesis in hypercholesterolemic rabbit model with acute hindlimb ischemia |
| Q36075172 | Targeting cerebral arteries for gene therapy |
| Q35080395 | Therapeutic angiogenesis with vascular endothelial growth factor in peripheral and coronary artery disease: a review |
| Q35949638 | Therapeutic myocardial angiogenesis with vascular endothelial growth factors |
| Q39677727 | Tissue-engineered provisional matrix as a novel approach to enhance diabetic wound healing |
| Q40199219 | Treatment of heart failure by calcium cycling gene therapy |
| Q77626402 | VEGF therapy in heart disease: for better or for worse? |
| Q39741051 | VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. |
Search more.